Protection against influenza virus infection by nasal vaccination in advance of sublethal irradiation (Q45742913)

15 December 2017

title

Protection against influenza virus infection by nasal vaccination in advance of sublethal irradiation (English)

1 reference

15 December 2017

author name string

Hasegawa H

1

1 reference

15 December 2017

Kadowaki S

2

1 reference

15 December 2017

Takahashi H

3

1 reference

15 December 2017

Iwasaki T

4

1 reference

15 December 2017

Tamura S

5

1 reference

15 December 2017

Kurata T

6

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

18

1 reference

15 December 2017

page(s)

2560-2565

1 reference

15 December 2017

issue

23

1 reference

15 December 2017

Human marrow transplantation: an immunological perspective

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Structural basis of immune recognition of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Varicella vaccination in children after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Immunity to influenza in man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Secretory anti-influenza immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Immunoglobulin A: strategic defense initiative at the mucosal surface

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Plaque assay and primary isolation of influenza a viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Reaginic antibody formation in the mouse. XI. Participation of long-lived antibody-forming cells in persistent antibody formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Isolation and characterization of mouse nasal-associated lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Purified influenza virus nucleoprotein protects mice from lethal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900553-8

7 January 2021

10.1016/S0264-410X(99)00553-8

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

10775790

1 reference

15 December 2017